Struma ovarii natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally excellent under benign conditions | *Prognosis is generally excellent under benign conditions and in malignant cases, adjuvant iodine-131 ablation with surgical extirpation has excellent prognosis | ||
*The 5/10/20-year mortality/survival rate of patients with Struma ovarii is approximately 96.7%, 94.3%, and 84.9%, respectively. | *The 5/10/20-year mortality/survival rate of patients with Struma ovarii is approximately 96.7%, 94.3%, and 84.9%, respectively. | ||
* In adults with differentiated thyroid cancer who are treated with high doses of radioiodine seem to have an excellent long-term prognosis. <ref name="pmid25474425">{{cite journal |vauthors=Luo JR, Xie CB, Li ZH |title=Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature |journal=Medicine (Baltimore) |volume=93 |issue=26 |pages=e147 |year=2014 |pmid=25474425 |pmc=4616397 |doi=10.1097/MD.0000000000000147 |url=}}</ref> | *In adults with differentiated thyroid cancer who are treated with high doses of radioiodine seem to have an excellent long-term prognosis. <ref name="pmid25474425">{{cite journal |vauthors=Luo JR, Xie CB, Li ZH |title=Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature |journal=Medicine (Baltimore) |volume=93 |issue=26 |pages=e147 |year=2014 |pmid=25474425 |pmc=4616397 |doi=10.1097/MD.0000000000000147 |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 12:23, 22 August 2017
|
Struma ovarii Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Struma ovarii natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Struma ovarii natural history, complications and prognosis |
|
FDA on Struma ovarii natural history, complications and prognosis |
|
CDC on Struma ovarii natural history, complications and prognosis |
|
Struma ovarii natural history, complications and prognosis in the news |
|
Blogs on Struma ovarii natural history, complications and prognosis |
|
Risk calculators and risk factors for Struma ovarii natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- If left untreated Struma ovarii may lead to thyrotoxicosis [1]
- Advanced disease may lead to malignancy, metastases, excessive hormone production and may prove fatal. [2]
Complications
- The most feared complication of struma ovarii is thyrotoxicosis. Other complications include due to metastasis of stroma oavrii.[3]
Prognosis
- Prognosis is generally excellent under benign conditions and in malignant cases, adjuvant iodine-131 ablation with surgical extirpation has excellent prognosis
- The 5/10/20-year mortality/survival rate of patients with Struma ovarii is approximately 96.7%, 94.3%, and 84.9%, respectively.
- In adults with differentiated thyroid cancer who are treated with high doses of radioiodine seem to have an excellent long-term prognosis. [4]
References
- ↑ Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P (2007). "Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism". Fertil. Steril. 88 (2): 497.e15–7. doi:10.1016/j.fertnstert.2006.11.095. PMC 2753978. PMID 17276434.
- ↑ Matsuda K, Maehama T, Kanazawa K (2001). "Malignant struma ovarii with thyrotoxicosis". Gynecol. Oncol. 82 (3): 575–7. doi:10.1006/gyno.2001.6315. PMID 11520159.
- ↑ Luo JR, Xie CB, Li ZH (2014). "Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature". Medicine (Baltimore). 93 (26): e147. doi:10.1097/MD.0000000000000147. PMC 4616397. PMID 25474425.